COV:CA Covalon Technologies Ltd.

CAD 1.09 -0.11 -9.166667
Icon

Covalon Technologies Ltd. (COV:CA) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | TSV
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

CAD 1.09

-0.11 (-9.17)%

CAD 0.03B

0.02M

N/A

N/A

Icon

COV:CA

Covalon Technologies Ltd. (CAD)
COMMON STOCK | TSV
CAD 1.09
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

CAD 0.03B

N/A

CAD 1.09

Covalon Technologies Ltd. (COV:CA) Stock Forecast

N/A

Based on the Covalon Technologies Ltd. stock forecast from 0 analysts, the average analyst target price for Covalon Technologies Ltd. is not available over the next 12 months. Covalon Technologies Ltd.’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Covalon Technologies Ltd. is Slightly Bearish, which is based on 3 positive signals and 4 negative signals. At the last closing, Covalon Technologies Ltd.’s stock price was CAD 1.09. Covalon Technologies Ltd.’s stock price has changed by -0.91% over the past week, -17.42% over the past month and -45.50% over the last year.

No recent analyst target price found for Covalon Technologies Ltd.
No recent average analyst rating found for Covalon Technologies Ltd.

Company Overview Covalon Technologies Ltd.

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The...Read More

N/A

N/A

0

N/A

CAD

Canada

Adjusted Closing Price for Covalon Technologies Ltd. (COV:CA)

Loading...

Unadjusted Closing Price for Covalon Technologies Ltd. (COV:CA)

Loading...

Share Trading Volume for Covalon Technologies Ltd. Shares

Loading...

Compare Performance of Covalon Technologies Ltd. Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for COV:CA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Covalon Technologies Ltd. (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NGEN:CA
NervGen Pharma Corp +0.23 (+11.50%) CAD0.15B N/A -7.16

ETFs Containing COV:CA

Symbol Name COV:CA's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Covalon Technologies Ltd. (COV:CA) Stock

Stock Target Advisor's fundamental analysis for Covalon Technologies Ltd.'s stock is Slightly Bearish.

Unfortunately we do not have enough data on COV:CA's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on COV:CA's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on COV:CA's stock to indicate if its overvalued.

The last closing price of COV:CA's stock was CAD 1.09.

The most recent market capitalization for COV:CA is CAD 0.03B.

Unfortunately we do not have enough analyst data on COV:CA's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Covalon Technologies Ltd.'s stock.

As per our most recent records Covalon Technologies Ltd. has 0 Employees.

Sorry we do not have any infomation available on Covalon Technologies Ltd.'s address.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...